Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 1 2

Status

Recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Carcinoma, Non-Small-Cell Lung 187Neoplasm Metastasis 150Neoplasms 141Leukemia, Myeloid, Acute 138Colorectal Neoplasms 131Breast Neoplasms 120Melanoma 95Ovarian Neoplasms 93Prostatic Neoplasms 89Recurrence 85Multiple Myeloma 83Lung Neoplasms 78Pancreatic Neoplasms 77Glioblastoma 77Squamous Cell Carcinoma of Head and Neck 75Myelodysplastic Syndromes 66Lymphoma, Non-Hodgkin 65Triple Negative Breast Neoplasms 57Glioma 57Stomach Neoplasms 54Endometrial Neoplasms 51Precursor Cell Lymphoblastic Leukemia-Lymphoma 50Carcinoma, Renal Cell 49Brain Neoplasms 48Small Cell Lung Carcinoma 47Lymphoma, Large B-Cell, Diffuse 45Carcinoma, Hepatocellular 45Lymphoma, B-Cell 42Lymphoma, Follicular 40Advanced Solid Tumors 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Solid Tumors, Adult × 90 days × Clear all
NCT05430373 2026-04-14

GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors

Grit Biotechnology

Phase 1 Recruiting
31 enrolled
Other solid neoplasm

Solid Tumors, Adult

NCT05861895 2026-04-07

HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors

HighField Biopharmaceuticals Corporation

Phase 1 Recruiting
84 enrolled
Other solid neoplasm

Solid Tumors, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡